Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.360
+0.200 (4.81%)
At close: Sep 19, 2024, 4:00 PM
4.395
+0.034 (0.79%)
After-hours: Sep 19, 2024, 7:32 PM EDT

Zentalis Pharmaceuticals Market Cap

Zentalis Pharmaceuticals has a market cap or net worth of $310.03 million as of September 19, 2024. Its market cap has decreased by -82.73% in one year.

Market Cap
310.03M
Enterprise Value
-72.33M
1-Year Change
-82.73%
Ranking
Category
Stock Price
$4.36

Market Cap Chart

Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $762.70M to $310.03M, a decrease of -59.35%. That is a compound annual growth rate of -18.27%.

History

DateMarket Cap% Change
Sep 18, 2024295.80M-72.41%
Dec 29, 20231.07B-6.73%
Dec 30, 20221.15B-69.82%
Dec 31, 20213.81B80.54%
Dec 31, 20202.11B176.58%
Apr 3, 2020762.70M-
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Kamada 306.04M
PepGen 301.78M
ProKidney 301.26M
ADC Therapeutics 299.61M
Precigen 299.58M
Heron Therapeutics 295.75M
TScan Therapeutics 293.48M
SOPHiA GENETICS 289.33M
Market Cap Rankings